About Hema Pharmaceuticals
Hema Pharmaceuticals is a Healthcare company based in Ankleshwar (India) founded in 1988. It manufactures high-quality active pharmaceutical ingredients and other pharmaceutical products. It operates on a B2B model. The company has 66 employees. Its Indian entity Hema Pharmaceuticals Pvt Ltd reported revenue of ₹85.23 Cr. Its focus areas include Pharmaceuticals, Manufacturing and API Production. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Hema Pharmaceuticals manufactures high-quality active pharmaceutical ingredients and other pharmaceutical products through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api production. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Ankleshwar, India
- Employees 66
- SectorsHealthcare
- Email••••••••
- Website hemapharma.com
- Social LinkedIn
- Legal Name Hema Pharmaceuticals Pvt Ltd
- Date of Incorporation 11 Apr, 1988
- Jurisdiction Ankleshwar, Gujarat, India
- Annual Revenue₹85.23 Cr
FY 2025 · +17% YoY
- Net Profit₹2.85 Cr
FY 2025 · 3% margin
- EBITDA₹6.65 Cr
FY 2025 · 8% margin
- Employee Count66
Associated legal entities of Hema Pharmaceuticals
Hema Pharmaceuticals operates through Hema Pharmaceuticals Pvt Ltd (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hema Pharmaceuticals Pvt Ltd CIN U24230GJ1988PTC010557 | Active | 11 Apr 1988 | Ankleshwar, Gujarat | ₹85.2 Cr | 66 | 2 | View details |
Board of directors of Hema Pharmaceuticals Pvt Ltd (Hema Pharmaceuticals)
Hema Pharmaceuticals Pvt Ltd is the primary company behind Hema Pharmaceuticals. The board of Hema Pharmaceuticals Pvt Ltd currently have 2 directors; the longest-serving is Manishbhai Vrajlal Thumar, appointed in 2012. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manishbhai Vrajlal Thumar DIN 06392269 | Director | 22 Oct 2012 | 14 yrs | Hema Pharmaceuticals Pvt Ltd |
| Jigneshkumar Chhaganbhai Chodvadiya DIN 02917430 | Director | 31 Jul 2015 | 11 yrs 3 mo | Hema Pharmaceuticals Pvt Ltd |
People of Hema Pharmaceuticals
1 people are tracked at Hema Pharmaceuticals (1 in leadership); the tracked headcount is 66.
| Name | Role | Group |
|---|---|---|
| Owner | Leadership |
Complete people profiles for Hema Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Hema Pharmaceuticals
Figures of Hema Pharmaceuticals Pvt Ltd, the primary company behind Hema Pharmaceuticals, for FY 2025. Revenue was ₹85.23 Cr (+17% year on year). Net profit was ₹2.85 Cr (3% margin). EBITDA was ₹6.65 Cr (8% margin). Revenue has grown at a compounded annual rate of +1% over three years and +1% over five years.
- ₹85.23 CrRevenue · FY 2025 · +17% YoY
- ₹2.85 CrNet profit · 3% margin
- ₹6.65 CrEBITDA · 8% margin
- ₹69.8 LakhPaid-up capital
- 66Employees (provident fund records)
- +1%Revenue CAGR, 3 years
- +1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Hema Pharmaceuticals Pvt Ltd are on its company page.
Detailed financial statements for Hema Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Hema Pharmaceuticals
Hema Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Hema Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Hema Pharmaceuticals
The website of Hema Pharmaceuticals (hemapharma.com) receives about 1K visits a month.
- Monthly visits1K
▼ 38.2% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Hema Pharmaceuticals
Hema Pharmaceuticals was founded in 1988.
Hema Pharmaceuticals is headquartered in Ankleshwar, India. It is registered at Ankleshwar, Gujarat, India.
Hema Pharmaceuticals has 66 employees.
The primary company behind Hema Pharmaceuticals, Hema Pharmaceuticals Pvt Ltd, reported revenue of ₹85.23 Cr for FY 2025, up 17% year on year.
Hema Pharmaceuticals manufactures high-quality active pharmaceutical ingredients and other pharmaceutical products through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api production. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Hema Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and SeQuent.
Hema Pharmaceuticals operates through Hema Pharmaceuticals Pvt Ltd.
The legal entities of Hema Pharmaceuticals currently have 2 directors, including Jigneshkumar Chhaganbhai Chodvadiya, Manishbhai Vrajlal Thumar.